Octreotide acetate - Excessive secretions in palliative care
You are here : Home > Formulary Search > Octreotide acetate - Excessive secretions in palliative care
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Injection
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Primary Care may be asked to prescribe on recommendation from the specialist palliative care team.
Note: excessive respiratory secretions in palliative care would be treated with glycopyrronium bromide, hyoscine hydrobromide or hyoscine butylbromide for which there are separate formulary entries
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Octreotide acetate
Indication :
Excessive secretions in palliative care
Group Name :
Keywords :
intestinal secretions, malignant bowel obstruction, reduction of secretions, high-volume output, intractable diarrhoea, tumour secretions
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (0)
- No records returned.
Other Indications
Below are listed other indications that Octreotide acetate is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Excessive secretions in palliative care.